Hand‐foot syndrome following prolonged infusion of high doses of vinorelbine

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Cancer

• Publication date

  1998-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0142(19980301)82:5<965::AID-CNCR23>3.0.CO;2-YPMID 9486588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hand‐foot syndrome associated with liposome‐encapsulated doxorubicin therapy

  1995cited by this paper
• Current status of vinorelbine for breast cancer.

  1995cited by this paper
• Cancer statistics, 1995

  1995cited by this paper
• A summary of vinorelbine (Navelbine) safety data from North American clinical trials.

  1994cited by this paper
• Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer.

  1994cited by this paper
• The clinical pharmacokinetics of vinorelbine (Navelbine).

  1994cited by this paper
• Palmar-plantar erythrodysestasia syndrome associated with 5-fluorouracil treatment.

  1993cited by this paper
• Overview of new treatments for breast cancer

  1992cited by this paper
• Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion

  1990cited by this paper
• Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome.

  1984cited by this paper
• Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer.

  1980cited by this paper

• Unveiling the anticancer power of vinca rosea leaves: A pharmacognostical and phytochemical approach

  2025cites this paper
• A phase II study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in patients with colorectal cancer receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study)

  2025cites this paper
• Alkaloids in Cancer therapy: Targeting the tumor microenvironment and metastasis signaling pathways.

  2024cites this paper
• Survival Analysis in Metastasis Breast Cancer with HER-2 Type That Received Vinorelbine And Capecitabine Chemotherapy at Prof. Dr.I.G.N.G. Ngoerah Central General Hospital

  2024cites this paper
• Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study)

  2022cites this paper
• Pyoderma gangrenosum arising on vinorelbine infusion site with additional histopathological features of syringosquamous metaplasia

  2020cites this paper
• Dermatological Toxicities of Chemotherapy

  2020cites this paper
• Entwicklung eines Pyoderma gangraenosum an der Infusionsstelle von Vinorelbin mit zusätzlichen histopathologischen Merkmalen einer syringo‐squamösen Metaplasie

  2020cites this paper
• Common Cutaneous Side Effects of Anti-cancer Agents

  2019cites this paper
• Dermatologic Cancer Pain Syndromes

  2018cites this paper
• Palmar‐plantar erythrodysesthesia syndrome following treatment with high‐dose methotrexate or high‐dose cytarabine

  2017cites this paper
• Uncommon Adverse Effects of Commonly Used Chemotherapeutic Agents in Medical Oncology Practice: A Series of Two Cases of Hand-Foot Syndrome

  2017influential citation
• [Safety of reintroduction of erlotinib at low doses following hand-foot syndrome induced by erlotinib treatment for a Pancoast-Tobias tumour].

  2014cites this paper
• Palmoplantar Erythrodysesthesia-Like Skin Symptoms in Patients under Various Chemotherapeutics: Preventive and Therapeutic Options

  2014cites this paper
• Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. Conventional chemotherapeutic drugs.

  2014cites this paper
• Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer: Part II. Targeted therapy.

  2014cites this paper
• Hand, foot and scrotal blisters in a patient with cancer receiving oral chemotherapy

  2014cites this paper
• Efficient Prevention Strategy against the Development of a Palmar-Plantar Erythrodysesthesia during Chemotherapy

  2013cites this paper
• Vinca Alkaloids

  2013cites this paper
• Erupción eritematosa supravenosa persistente por vinorelbina

  2012cites this paper
• Capecitabine and hand–foot syndrome

  2011cites this paper
• Síndrome de manos y pies en pacientes con cáncer de mama metastásico asociado al tratamiento con quimioterapia

  2010cites this paper
• Reviews in Oncology Capecitabine Associated Hand-Foot Syndrome : A Review

  2010cites this paper
• Reações tegumentares adversas relacionadas aos agentes antineoplásicos: parte I

  2010cites this paper
• Adverse mucocutaneous reactions to chemotherapeutic agents: part I.

  2010cites this paper
• Compliance and Effective Management of the Hand-Foot Syndrome in Colon Cancer Patients Receiving Capecitabine as Adjuvant Chemotherapy

  2009cites this paper
• Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and Sunitinib

  2009cites this paper
• The pathogenetic mechanism of anthracycline-induced palmar-plantar erythrodysesthesia.

  2009cites this paper
• Cutaneous reactions to chemotherapy: commonly seen, less described, little understood.

  2008cites this paper
• Chemotherapeutic agents and the skin: An update.

  2008cites this paper
• Hand–foot syndrome in breast cancer patients receiving adjuvant chemotherapy

  2007cites this paper
• Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.

  2007cites this paper
• The hand-foot syndrome--a frequent secondary manifestation in antineoplastic chemotherapy.

  2006cites this paper
• Dermatologic toxicity of chemotherapeutic agents.

  2006cites this paper
• Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction.

  2006cites this paper
• Management of hand-foot syndrome induced by capecitabine

  2006cites this paper
• Vascular toxicity of antineoplastic agents.

  2006cites this paper
• Hand-foot syndrome in a patient with multiple fire ant stings.

  2004cites this paper
• Liposomal anthracycline administration and toxicity management: a nursing perspective.

  2004cites this paper
• Management of hand-foot syndrome in patients treated with capecitabine (Xeloda).

  2004cites this paper
• Coming to grips with hand-foot syndrome. Insights from clinical trials evaluating capecitabine.

  2004cites this paper
• Hand‐Foot Syndrome in Patients Treated With Capecitabine‐Containing Combination Chemotherapy

  2004cites this paper
• Phase I Study of Doxil® and Vinorelbine in Patients with Advanced Malignancies

  2004cites this paper
• Penile Involvement with Hand-Foot Syndrome

  2004cites this paper
• Vinorelbine as a 96-hour continuous infusion in heavily pretreated patients with metastatic breast cancer: a cooperative study by the GEICAM group.

  2003cites this paper
• Incidence and Severity of Hand–Foot Syndrome in Colorectal Cancer Patients Treated with Capecitabine: A Single-Institution Experience

  2002cites this paper
• Single-agent capecitabine: a reference treatment for taxane-pretreated metastatic breast cancer?

  2002cites this paper
• Hand-foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine.

  2001cites this paper
• Tubulin targeting agents.

  2001cites this paper
• Phase I–II Vinorelbine (Navelbine®) by Continuous Infusion in Patients with Metastatic Breast Cancer: Cumulative Toxicities Limit Dose Escalation

  2001influential citation
• Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer.

  2000cites this paper
• Antineoplastic Therapy—Induced Palmar Plantar Erythrodysesthesia (‘Hand-Foot’) Syndrome

  2000cites this paper
• Pyridoxine for Hand–Foot Syndrome

  1999cites this paper
• Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

  1999cites this paper
• Undifferentiated carcinoma with osteoclast‐like giant cells of the pancreas and periampullary region

  1998cites this paper
• Radiation‐induced sarcoma‐‐50 years later

  1998cites this paper
• Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma

  1998cites this paper
• Intensified therapy for infants with acute lymphoblastic leukemia

  1998cites this paper
• Hand‐foot syndrome following prolonged infusion of high doses of vinorelbine

  1998cites this paper
• Radiation‐induced sarcoma‐50 years later

  1998cites this paper
• Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma

  1998cites this paper
• Report of a panel on the relationship between public exposure to pesticides and cancer

  1998cites this paper
• Cancer among spouses

  1998cites this paper